Yüklüyor......
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein
OBJECTIVE: The recent availability of novel antiviral drugs has raised new hope for a more effective treatment of hepatitis C virus (HCV) infection and its severe sequelae. However, in the case of non-responding or relapsing patients, alternative strategies are needed. To this end we have used chime...
Kaydedildi:
| Yayımlandı: | Gut |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4789830/ https://ncbi.nlm.nih.gov/pubmed/25661083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2014-308316 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|